FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ingrid Pabinger

Research Profile

Concepts & Ideas

Disorders

Chemicals & Drugs

Co-author Network

Publications

TOP 3
J Haselboeck; Alexandra Kaider; Ingrid Pabinger; Simon Panzer
Function of eltrombopag-induced platelets compared to platelets from control patients with immune thrombocytopenia.
Francesco Rodeghiero; Marco Ruggeri; Alberto Tosetto; Victor Blanchette; James B Bussel; Douglas B Cines; Nichola Cooper; Terry Gernsheimer; Bertrand Godeau; Andreas Greinacher; Paul Imbach; Mehdi Khellaf; Robert J Klaassen; Thomas Kühne; Howard Liebman; Maria Gabriella Mazzucconi; Marc Michel; Adrian Newland; Ingrid Pabinger; Roberto Stasi
Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group.
Johannes Thaler; Werner Scheithauer; Judith Stift; Cihan Ay; Michael Gnant; Alexandra Kaider; Nigel Mackman; Sylvia Metz-Schimmerl; Leonhard Müllauer; Ingrid Pabinger
Microparticle-associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ingrid Pabinger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: J Haselboeck; Alexandra Kaider; Ingrid Pabinger; Simon Panzer
Function of eltrombopag-induced platelets compared to platelets from control patients with immune thrombocytopenia.
Thrombosis and haemostasis 2013;109(4):676-83.
2013: Francesco Rodeghiero; Marco Ruggeri; Alberto Tosetto; Victor Blanchette; James B Bussel; Douglas B Cines; Nichola Cooper; Terry Gernsheimer; Bertrand Godeau; Andreas Greinacher; Paul Imbach; Mehdi Khellaf; Robert J Klaassen; Thomas Kühne; Howard Liebman; Maria Gabriella Mazzucconi; Marc Michel; Adrian Newland; Ingrid Pabinger; Roberto Stasi
Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group.
Blood 2013;121(14):2596-606.
2013: Johannes Thaler; Werner Scheithauer; Judith Stift; Cihan Ay; Michael Gnant; Alexandra Kaider; Nigel Mackman; Sylvia Metz-Schimmerl; Leonhard Müllauer; Ingrid Pabinger
Microparticle-associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features.
European journal of clinical investigation 2013;43(3):277-85.
2013: Johannes Thaler; Christoph Zielinski; Cihan Ay; Alexandra Kaider; Christine Marosi; Ingrid Pabinger; Matthias Preusser; Johannes A Hainfellner
Intratumoral tissue factor expression and risk of venous thromboembolism in brain tumor patients.
Thrombosis research 2013;131(2):162-5.
2013: Sylvia Reitter-Pfoertner; Thomas Waldhoer; Cihan Ay; Ernst Eigenbauer; Paul A Kyrle; Christine Mannhalter; Matthias Mayerhofer; Ingrid Pabinger
The influence of thrombophilia on the long-term survival of patients with a history of venous thromboembolism.
Thrombosis and haemostasis 2013;109(1):79-84.
2012: Johannes Thaler; Cihan Ay; Ingrid Pabinger
Venous thromboembolism in cancer patients - risk scores and recent randomised controlled trials.
Thrombosis and haemostasis 2012;108(6):1042-8.
2012: Jerry S Powell; Lawrence Schwartz; Jerzy Windyga; Giovanni Di Minno; Andrzej Hellmann; Jørgen Ingerslev; Monika Maas Enriquez; Uri martinowitz; Ingrid Pabinger
Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients. A randomised, active-controlled, double-blind study.
Thrombosis and haemostasis 2012;108(5):913-22.
2012: Jonas Ahlbrecht; Cihan Ay; Boris Dickmann; Daniela Dunkler; Andrea Haitel; Peter Quehenberger; Manuela Schmidinger; Johannes Thaler; Christoph Zielinski; Ingrid Pabinger
Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(31):3870-5.
2012: Joannis Panotopoulos; Verena Stockhammer; Klemens Trieb; Cihan Ay; Philipp T Funovics; Johannes Holinka; Susanna Lang; Ingrid Pabinger; Reinhard Windhager; Hugo A Wanivenhaus
Surgical treatment of the haemophilic pseudotumour: a single centre experience.
International orthopaedics 2012;36(10):2157-62.
2012: Sylvia Reitter-Pfoertner; Raute Sunder-Plassmann; Vera Tiedje; Arndt von Haeseler; Birgit Horvath; Ingrid Pabinger; Christine Mannhalter
Identification of an ancient haemophilia A splice site mutation.
Thrombosis research 2012;130(3):445-50.
2012: M E Gorczyca; Bernd Jilma; Paul Knoebl; Christoph Male; K E McGinness; S C Nair; Ingrid Pabinger; S Priya; S Reitter; R G Schaub; Michael Dockal; J C Gilbert; A Srivastava
Inhibition of tissue factor pathway inhibitor by the aptamer BAX499 improves clotting of hemophilic blood and plasma.
Journal of thrombosis and haemostasis : JTH 2012;10(8):1581-90.
2012: Cihan Ay; Daniela Dunkler; Robert Pirker; Peter Quehenberger; Johannes Thaler; Oswald Wagner; Christoph Zielinski; Ingrid Pabinger
High D-dimer levels are associated with poor prognosis in cancer patients.
Haematologica 2012;97(8):1158-64.
2012: J Thaler; Christoph Zielinski; Werner Scheithauer; Cihan Ay; D A Barcel; R M Bertina; A Kaider; Nigel S Key; G Kornek; Nigel Mackman; C Marosi; Ingrid Pabinger
Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients.
Journal of thrombosis and haemostasis : JTH 2012;10(7):1363-70.
2012: Cihan Ay; Peter Husslein; Alexandra Kaider; Silvia Koder; Ingrid Pabinger
Association of elevated soluble P-selectin levels with fetal loss in women with a history of venous thromboembolism.
Thrombosis research 2012;129(6):725-8.
2012: Leyla Ay; Johanna-Maria Brix; Florian Hoellerl; Silvia Koder; Ingrid Pabinger; Cihan Ay; Gerit-Holger Schernthaner; Guntram Schernthaner
Thrombin generation in type 2 diabetes with albuminuria and macrovascular disease.
European journal of clinical investigation 2012;42(5):470-7.
2012: Cihan Ay; Ingrid Pabinger
Predictive potential of haemostatic biomarkers for venous thromboembolism in cancer patients.
Thrombosis research 2012;129 Suppl 1():S6-9.
2012: Sylvia Reitter-Pfoertner; Raute Sunder-Plassmann; Birgit Horvath; Klaus Lechner; Christine Mannhalter; Ingrid Pabinger
Inhibitor development in two patients with mild haemophilia A - spontaneous disappearance and no recurrence of the inhibitor after re-challenge.
Wiener klinische Wochenschrift 2012;124(5-6):198-201.
2012: Ingrid Pabinger; Simon Panzer; Elisabeth Pittermann; Siegfried Sormann; Michael Steurer; Josef Thaler; Michael Fillitz; Josef Friedl; Günther Gastl; Dietmar Geissler; Klaus Geissler; Richard Greil; Paul Knoebl; Sibylle A Kozek-Langenecker; Peter Krippl; Paul Kyrle; Alois Lang; Werner Linkesch; Heinz Ludwig; Markus Müller; Ansgar Weltermann
[Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (ÖGHO)].
Wiener klinische Wochenschrift 2012;124(3-4):111-23.
2012: Ingrid Pabinger; P Svensson; C Y Vossen; J Conard; M C García-Dabrio; A Kaider; J Lang; C Legnani; W Miesbach; Frits R Rosendaal
Mortality and inherited thrombophilia: results from the European Prospective Cohort on Thrombophilia.
Journal of thrombosis and haemostasis : JTH 2012;10(2):217-22.
2012: Cihan Ay; Ingrid Pabinger
[Tumor and thrombosis].
Hämostaseologie 2012;32(2):94.
2012: Ingrid Pabinger; Cihan Ay
Risk of venous thromboembolism and primary prophylaxis in cancer. Should all patients receive thromboprophylaxis?
Hämostaseologie 2012;32(2):132-7.
2012: Cihan Ay; Ingrid Pabinger
Treatment and secondary prevention of venous thromboembolism in cancer patients. Current strategies and new therapeutic options.
Hämostaseologie 2012;32(2):139-44.
2012: J Thaler; Cihan Ay; Ingrid Pabinger
Clinical significance of circulating microparticles for venous thromboembolism in cancer patients.
Hämostaseologie 2012;32(2):127-31.
2011: Ingrid Pabinger; B Alt-Epping; F Demarmels Biasutti; F Langer; B Wörmann; H Riess
[Venous thrombembolism in tumour patients].
Hämostaseologie 2011;31(4):281-90; quiz 291-2.
2011: V Tiedje; C Zielinski; Ingrid Pabinger; M Pabinger; Peter Quehenberger; Cihan Ay; Daniela Dunkler; B Horvath; Christine Mannhalter
The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis.
Thrombosis and haemostasis 2011;106(5):908-13.
2011: Klaus Lechner; Johanna Haselböck; Ulrich Jäger; Ingrid Simonitsch; Ingrid Pabinger
Acquired immune-mediated thrombophilia in lymphoproliferative disorders.
Leukemia & lymphoma 2011;52(10):1836-43.
2011: S Reitter; Ingrid Pabinger; Paul Knoebl; Klaus Lechner
Postoperative paraneoplastic factor VIII auto-antibodies in patients with solid tumours.
Haemophilia : the official journal of the World Federation of Hemophilia 2011;17(5):e889-94.
2011: Cihan Ay; Johanna Haselböck; Silvia Koder; Clarissa Laczkovics; Ingrid Pabinger
Thrombin generation in patients with a bleeding tendency of unknown origin.
Annals of hematology 2011;90(9):1099-104.
2011: Cihan Ay; Daniela Dunkler; Ralph Simanek; Johannes Thaler; Silvia Koder; Christine Marosi; Christoph Zielinski; Ingrid Pabinger
Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(15):2099-103.
2011: Sylvia Elisabeth Reitter; Thomas Waldhoer; Matthias Mayerhofer; Ernst Eigenbauer; Cihan Ay; Paul Alexander Kyrle; Ingrid Pabinger
Long-term survival of patients with a history of venous thromboembolism.
Annals of hematology 2011;90(5):585-94.
2011: Johannes Thaler; Cihan Ay; Harald Weinstabl; Daniela Dunkler; Ralph Simanek; Rainer Vormittag; Jean-Marie Freyssinet; Christoph Zielinski; Ingrid Pabinger
Circulating procoagulant microparticles in cancer patients.
Annals of hematology 2011;90(4):447-53.
2011: R Kanz; Thomas Vukovich; Rainer Vormittag; Daniela Dunkler; Cihan Ay; J Thaler; J Haselböck; Werner Scheithauer; Christoph Zielinski; Ingrid Pabinger
Thrombosis risk and survival in cancer patients with elevated C-reactive protein.
Journal of thrombosis and haemostasis : JTH 2011;9(1):57-63.
2010: Cihan Ay; Daniela Dunkler; Christine Marosi; Alexandru-Laurentiu Chiriac; Rainer Vormittag; Ralph Simanek; Peter Quehenberger; Christoph Zielinski; Ingrid Pabinger
Prediction of venous thromboembolism in cancer patients.
Blood 2010;116(24):5377-82.
2010: Roberto Stasi; Adrian Newland; Patrick Thornton; Ingrid Pabinger
Should medical treatment options be exhausted before splenectomy is performed in adult ITP patients? A debate.
Annals of hematology 2010;89(12):1185-95.
2010: David J Kuter; Mathias Rummel; Ralph V Boccia; B Gail Macik; Ingrid Pabinger; Dominik Selleslag; Francesco Rodeghiero; Beng H Chong; Xuena Wang; Dietmar P Berger
Romiplostim or standard of care in patients with immune thrombocytopenia.
The New England journal of medicine 2010;363(20):1889-99.
2010: Gregor Hron; Paul A Kyrle; Alexandra Kaider; Karl Philipp; Ingrid Pabinger; Marietta Kollars; Sabine Eichinger
ProCGlobal and endogenous thrombin potential during pregnancy.
American journal of obstetrics and gynecology 2010;203(5):463.e1-6.
2010: Sylvia Reitter; Clarissa Laczkovics; Thomas Waldhoer; Matthias Mayerhofer; Christian Vutuc; Ingrid Pabinger
Long-term survival after venous thromboembolism: a retrospective selected cohort study among young women.
Haematologica 2010;95(8):1425-8.
2010: Sylvia Reitter; Rümuth Sturn; Birgit Horvath; Renate Freitag; Christoph Male; Wolfgang Muntean; Werner Streif; Ingrid Pabinger; Christine Mannhalter
Spectrum of causative mutations in patients with haemophilia A in Austria.
Thrombosis and haemostasis 2010;104(1):78-85.
2010: Cihan Ay; Ingrid Pabinger
Tests predictive of thrombosis in cancer.
Thrombosis research 2010;125 Suppl 2():S12-5.
2010: Ingrid Pabinger; Andreas Tiede; Uwe Kalina; Sigurd Knaub; Reinhard Germann; Helmut Ostermann
Impact of infusion speed on the safety and effectiveness of prothrombin complex concentrate: a prospective clinical trial of emergency anticoagulation reversal.
Annals of hematology 2010;89(3):309-16.
2010: Ralph Simanek; Rainer Vormittag; Cihan Ay; G Alguel; Daniela Dunkler; I Schwarzinger; G Steger; U Jaeger; Christoph Zielinski; Ingrid Pabinger
High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).
Journal of thrombosis and haemostasis : JTH 2010;8(1):114-20.
2010: Cihan Ay; K Thom; F Abu-Hamdeh; B Horvath; Peter Quehenberger; Christoph Male; Christine Mannhalter; Ingrid Pabinger
Determinants of factor VIII plasma levels in carriers of haemophilia A and in control women.
Haemophilia : the official journal of the World Federation of Hemophilia 2010;16(1):111-7.
2009: Rainer Vormittag; Ralph Simanek; Cihan Ay; Daniela Dunkler; Peter Quehenberger; Christine Marosi; Christoph Zielinski; Ingrid Pabinger
High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(12):2176-81.
2009: S Reitter; R Sturn; W Streif; Thomas Schabetsberger; F Wozak; C Male; W Muntean; Ingrid Pabinger
[Austrian haemophilia registry: up-date 2008 ].
Hämostaseologie 2009;29 Suppl 1():S13-5.
2009: D Olcaydu; R C Skoda; R Looser; S Li; M Cazzola; D Pietra; F Passamonti; E Lippert; S Carillo; F Girodon; A Vannucchi; N S Reading; josef prchal; Cihan Ay; Ingrid Pabinger; Heinz Gisslinger; Robert Kralovics
The 'GGCC' haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera.
Leukemia 2009;23(10):1924-6.
2009: Cihan Ay; Rainer Vormittag; Daniela Dunkler; Ralph Simanek; Alexandru-Laurentiu Chiriac; Johannes Drach; Peter Quehenberger; Oswald Wagner; Christoph Zielinski; Ingrid Pabinger
D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(25):4124-9.
2009: S Reitter; T Waldhoer; Christian Vutuc; Klaus Lechner; Ingrid Pabinger
Survival in a cohort of patients with haemophilia at the haemophilia care center in Vienna, Austria, from 1983 to 2006.
Haemophilia : the official journal of the World Federation of Hemophilia 2009;15(4):888-93.
2009: K Thom; Christoph Male; Jutta Falger; Ingrid Pabinger
Spontaneous disappearance of high titre factor VIII inhibitor 15 years after unsuccessful ITI.
Hämostaseologie 2009;29(2):149-50.
2009: Damla Olcaydu; Ashot Harutyunyan; Roland Jäger; Tiina Berg; Bettina Gisslinger; Ingrid Pabinger; Heinz Gisslinger; Robert Kralovics
A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms.
Nature genetics 2009;41(4):450-4.
2009: Ingrid Pabinger; Andreas Greinacher
Anti-factor xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxis.
Obstetrics and gynecology 2009;113(3):740; author reply 740-1.
2009: Ingrid Pabinger; Cihan Ay
Biomarkers and venous thromboembolism.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(3):332-6.
2009: Amy D Shapiro; Ralph Gruppo; Ingrid Pabinger; Peter W Collins; Charles R M Hay; Phillip Schroth; Kathleen Casey; Lisa Patrone; Hartmut Ehrlich; Bruce M Ewenstein
Integrated analysis of safety and efficacy of a plasma- and albumin-free recombinant factor VIII (rAHF-PFM) from six clinical studies in patients with hemophilia A.
Expert opinion on biological therapy 2009;9(3):273-83.
2009: Cihan Ay; Jean-Marie Freyssinet; Thomas Sailer; Rainer Vormittag; Ingrid Pabinger
Circulating procoagulant microparticles in patients with venous thromboembolism.
Thrombosis research 2009;123(5):724-6.
2009: Simon Panzer; Ingrid Pabinger
Eltrombopag in chronic idiopathic thrombocytopenic purpura.
Lancet 2009;373(9664):607-8.
2009: Sylvia Reitter; Werner Streif; Thomas Schabetsberger; Florian Wozak; Hubert Hartl; Christoph Male; Wolfgang Muntean; Ingrid Pabinger
Austrian Hemophilia Registry: design, development and set of variables.
Wiener klinische Wochenschrift 2009;121(5-6):196-201.
2009: Veronika Fialka-Moser; Christa Fonatsch; Erika Jensen-Jarolim; Renate Koppensteiner; Irene Lang; Christine Mannhalter; Ingrid Pabinger; Margit Pavelka; Eva Piehslinger; Anita Rieder; Ursula Schmidt-Erfurth; Veronika Sexl; Maria Sibillia; Marianne Springer-Kremser; Ursula Wiedermann
[The Club of Female Professors of the Medical University Vienna].
Wiener medizinische Wochenschrift (1946) 2009;159(3-4):95-109.
2009: Ingrid Pabinger
Thrombophilia and its impact on pregnancy.
Thrombosis research 2009;123 Suppl 3():S16-21.
2008: Cihan Ay; Ralph Simanek; Rainer Vormittag; Daniela Dunkler; Guelay Alguel; Silvia Koder; Gabriela Kornek; Christine Marosi; Oswald Wagner; Christoph Zielinski; Ingrid Pabinger
High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).
Blood 2008;112(7):2703-8.
2008: Claude Négrier; Amy D Shapiro; Erik Berntorp; Ingrid Pabinger; Michael D. Tarantino; Anastassios Retzios; Phillip Schroth; Bruce Ewenstein
Surgical evaluation of a recombinant factor VIII prepared using a plasma/albumin-free method: efficacy and safety of Advate in previously treated patients.
Thrombosis and haemostasis 2008;100(2):217-23.
2008: Maria-Theresa Krauth; Klaus Lechner; Edmund A M Neugebauer; Ingrid Pabinger
The postoperative splenic/portal vein thrombosis after splenectomy and its prevention--an unresolved issue.
Haematologica 2008;93(8):1227-32.
2008: H K Hartl; S Reitter; U Eidher; H Ramschak; Cihan Ay; Ingrid Pabinger
The impact of severe haemophilia on the social status and quality of life among Austrian haemophiliacs.
Haemophilia : the official journal of the World Federation of Hemophilia 2008;14(4):703-8.
2008: Shannon M Bates; Ian A Greer; Ingrid Pabinger; Shoshanna Sofaer; Jack Hirsh
Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Chest 2008;133(6 Suppl):844S-886S.
2008: Cihan Ay; Lea V Jungbauer; Alexandra Kaider; Silvia Koder; Simon Panzer; Ingrid Pabinger; Christine Mannhalter
P-selectin gene haplotypes modulate soluble P-selectin concentrations and contribute to the risk of venous thromboembolism.
Thrombosis and haemostasis 2008;99(5):899-904.
2008: Ingrid Pabinger; B Brenner; U Kalina; S Knaub; A Nagy; H Ostermann
Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial.
Journal of thrombosis and haemostasis : JTH 2008;6(4):622-31.
2008: Ingrid Pabinger
Thrombophilia and its impact on pregnancy.
Hämostaseologie 2008;28(3):130-4.
2008: Thomas Sailer; Rainer Vormittag; Silvia Koder; Peter Quehenberger; Alexandra Kaider; Ingrid Pabinger
Clinical significance of anti-protein Z antibodies in patients with lupus anticoagulant.
Thrombosis research 2008;122(2):153-60.
2008: Simon Panzer; Sergio Rosales; Heinz Gisslinger; Lea Jungbauer; Alexandra Kaider; Paul Knoebl; Christian Sillaber; Ingrid Pabinger
Plasma levels of P-selectin are determined by platelet turn-over and the P-selectin Thr715Pro polymorphism.
Thrombosis research 2008;121(4):573-9.
2007: Guelay Alguel; Kristin Jochmans; Ralph Simanek; Cihan Ay; Peter Quehenberger; Martin Langer; Ingrid Pabinger
Successful outcome in a pregnant woman with homozygous antithrombin deficiency.
Thrombosis and haemostasis 2007;98(6):1377-8.
2007: Helmut Ostermann; Sabine Haertel; Sigurd Knaub; Uwe Kalina; Kerstin Jung; Ingrid Pabinger
Pharmacokinetics of Beriplex P/N prothrombin complex concentrate in healthy volunteers.
Thrombosis and haemostasis 2007;98(4):790-7.
2007: Cihan Ay; Peter Bencur; Rainer Vormittag; Thomas Sailer; Christof Jungbauer; Thomas Vukovich; Christine Mannhalter; Ingrid Pabinger
The angiotensin-converting enzyme insertion/deletion polymorphism and serum levels of angiotensin-converting enzyme in venous thromboembolism. Data from a case control study.
Thrombosis and haemostasis 2007;98(4):777-82.
2007: Simon Panzer; Miriam Rieger; Rainer Vormittag; Beate Eichelberger; Daniela Dunkler; Ingrid Pabinger
Platelet function to estimate the bleeding risk in autoimmune thrombocytopenia.
European journal of clinical investigation 2007;37(10):814-9.
2007: Petra Jilma-Stohlawetz; Bernd Jilma; Christine Mannhalter; Peter Bencur; Ingrid Pabinger; Rainer Vormittag; Daniela Dunkler; Simon Panzer
Platelet glycoprotein Ibalpha polymorphisms and function evaluated by the platelet function analyzer PFA-100 in patients with lupus anticoagulant: the association with thromboembolic disease.
Annals of hematology 2007;86(10):719-25.
2007: Ralph Simanek; Simon Panzer; Klaus Lechner; Ingrid Pabinger
Late spontaneous remissions in severe adult autoimmune thrombocytopenia.
Annals of hematology 2007;86(10):705-10.
2007: Clarissa Laczkovics; Helga Grafenhofer; Alexandra Kaider; Peter Quehenberger; Ralph Simanek; Christine Mannhalter; Klaus Lechner; Ingrid Pabinger
Risk of recurrence after a first venous thromboembolic event in young women.
Haematologica 2007;92(9):1201-7.
2007: Simon Panzer; Lisa Höcker; Miriam Rieger; Rainer Vormittag; Daniela Koren; Daniela Dunkler; Ingrid Pabinger
Agonist-inducible platelet activation in chronic idiopathic autoimmune thrombocytopenia.
European journal of haematology 2007;79(3):198-204.
2007: Christa Mersich; Werner Billes; Ingrid Pabinger; Alois Jungbauer
Peptides derived from a secretory yeast library restore factor VIII activity in the presence of an inhibitory antibody.
Biotechnology and bioengineering 2007;98(1):12-21.
2007: Cihan Ay; Lea V Jungbauer; Thomas Sailer; Theres Tengler; Silvia Koder; Alexandra Kaider; Simon Panzer; Peter Quehenberger; Ingrid Pabinger; Christine Mannhalter
High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant.
Clinical chemistry 2007;53(7):1235-43.
2007: Peter Bugert; Ingrid Pabinger; Kathrin Stamer; Rainer Vormittag; Robert C Skeate; Monika M Wahi; Simon Panzer
The risk for thromboembolic disease in lupus anticoagulant patients due to pathways involving P-selectin and CD154.
Thrombosis and haemostasis 2007;97(4):573-80.
2007: Ralph Simanek; Rainer Vormittag; Marco Hassler; Karl Roessler; Martin Schwarz; Christoph Zielinski; Ingrid Pabinger; Christine Marosi
Venous thromboembolism and survival in patients with high-grade glioma.
Neuro-oncology 2007;9(2):89-95.
2007: Cihan Ay; Theres Tengler; Rainer Vormittag; Ralph Simanek; Wolfgang Dorda; Thomas Vukovich; Ingrid Pabinger
Venous thromboembolism--a manifestation of the metabolic syndrome.
Haematologica 2007;92(3):374-80.
2007: Rainer Vormittag; Peter Bencur; Cihan Ay; Theres Tengler; Thomas Vukovich; Peter Quehenberger; Christine Mannhalter; Ingrid Pabinger
Low-density lipoprotein receptor-related protein 1 polymorphism 663 C > T affects clotting factor VIII activity and increases the risk of venous thromboembolism.
Journal of thrombosis and haemostasis : JTH 2007;5(3):497-502.
2007: Ingrid Pabinger; Sabine Eichinger; Erich Minar; Herwig Niessner
[Austrian Guidelines for Prophylaxis of Venous Thromboembolism].
Wiener klinische Wochenschrift 2007;119(23-24):739-46.
2007: Maria-Theresa Krauth; Ingrid Pabinger
[Venous thromboembolism].
Wiener klinische Wochenschrift 2007;119(5-6 Suppl 1):11-8; quiz 19.
2007: Thomas Sailer; Rainer Vormittag; Claudia Zoghlami; Silvia Koder; Peter Quehenberger; Christoph Male; Ingrid Pabinger
The clinical significance of anti-prothrombin antibodies for risk assessment of thromboembolism in patients with lupus anticoagulant.
Thrombosis research 2007;120(2):295-302.
2007: Wolfgang R Sperr; Klaus Lechner; Ingrid Pabinger
Rituximab for the treatment of acquired antibodies to factor VIII.
Haematologica 2007;92(1):66-71.
2007: Rainer Vormittag; Thomas Vukovich; Milena Stain; Stephan Lehr; Erich Minar; Ingrid Pabinger
Lipoprotein (a) in patients with spontaneous venous thromboembolism.
Thrombosis research 2007;120(1):15-20.
2006: Simon Panzer; Lisa Höcker; Rainer Vormittag; Miriam Rieger; Daniela Koren; Daniela Dunkler; Ingrid Pabinger
Flow cytometric evaluation of platelet activation in chronic autoimmune thrombocytopenia.
Pediatric blood & cancer 2006;47(5 Suppl):694-6.
2006: Rainer Vormittag; M Funk; Christine Mannhalter; Verena Schönauer; Thomas Vukovich; Erich Minar; Christine Bialonczyk; Michael M Hirschl; Ingrid Pabinger
C-reactive protein 3' UTR +1444C>T polymorphism in patients with spontaneous venous thromboembolism.
Atherosclerosis 2006;188(2):406-11.
2006: Guelay Alguel; Rainer Vormittag; Ralph Simanek; Paul A Kyrle; Peter Quehenberger; Christine Mannhalter; Peter Husslein; Ingrid Pabinger
Preeclampsia and pregnancy loss in women with a history of venous thromboembolism and prophylactic low-molecular-weight heparin (LMWH) during pregnancy.
Thrombosis and haemostasis 2006;96(3):285-9.
2006: Thomas Sailer; Klaus Lechner; Simon Panzer; Paul A Kyrle; Ingrid Pabinger
The course of severe autoimmune thrombocytopenia in patients not undergoing splenectomy.
Haematologica 2006;91(8):1041-5.
2006: Georg Endler; Claudia Marsik; Bernd Jilma; Thomas Schickbauer; Rainer Vormittag; Oswald Wagner; Christine Mannhalter; Helmut Rumpold; Ingrid Pabinger
Anti-cardiolipin antibodies and overall survival in a large cohort: preliminary report.
Clinical chemistry 2006;52(6):1040-4.
2006: Klaus Lechner; Ansgar Weltermann; Ingrid Pabinger
[Adult autoimmune thrombocytopenia: diagnosis and treatment].
Wiener klinische Wochenschrift 2006;118(9-10):255-64.
2006: Rainer Vormittag; Kety Hsieh; Alexandra Kaider; Erich Minar; Christine Bialonczyk; Michael M Hirschl; Christine Mannhalter; Ingrid Pabinger
Interleukin-6 and interleukin-6 promoter polymorphism (-174) G > C in patients with spontaneous venous thromboembolism.
Thrombosis and haemostasis 2006;95(5):802-6.
2006: Thomas Sailer; Claudia Zoghlami; Christine Kurz; Helmut Rumpold; Peter Quehenberger; Simon Panzer; Ingrid Pabinger
Anti-beta2-glycoprotein I antibodies are associated with pregnancy loss in women with the lupus anticoagulant.
Thrombosis and haemostasis 2006;95(5):796-801.
2006: Eva-Maria Kopecky; Sabine Greinstetter; Ingrid Pabinger; Andrea Buchacher; Jürgen Römisch; Alois Jungbauer
Effect of oriented or random PEGylation on bioactivity of a factor VIII inhibitor blocking peptide.
Biotechnology and bioengineering 2006;93(4):647-55.
2006: Eva-Maria Kopecky; Sabine Greinstetter; Ingrid Pabinger; Andrea Buchacher; Jürgen Römisch; Alois Jungbauer
Mapping of FVIII inhibitor epitopes using cellulose-bound synthetic peptide arrays.
Journal of immunological methods 2006;308(1-2):90-100.
2006: Katharina Schallmoser; Christiane Rosin; Rainer Vormittag; Markus Brunner; Daniela Dunkler; Ingrid Pabinger; Simon Panzer
Specificities of platelet autoantibodies and platelet activation in lupus anticoagulant patients: a relation to their history of thromboembolic disease.
Lupus 2006;15(8):507-14.
2006: Rainer Vormittag; Ingrid Pabinger
Thrombophilia and pregnancy complications.
Hämostaseologie 2006;26(1):59-62.
2005: Eva-Maria Kopecky; Sabine Greinstetter; Ingrid Pabinger; Andrea Buchacher; Jürgen Römisch; Alois Jungbauer
Combinatorial peptides directed to inhibitory antibodies against human blood clotting factor VIII.
Thrombosis and haemostasis 2005;94(5):933-41.
2005: Rainer Vormittag; Thomas Vukovich; Christine Mannhalter; Erich Minar; Verena Schönauer; Christine Bialonczyk; Michael M Hirschl; Ingrid Pabinger
Haptoglobin phenotype 2-2 as a potentially new risk factor for spontaneous venous thromboembolism.
Haematologica 2005;90(11):1557-61.
2005: Carla Y Vossen; Isobel D Walker; Peter Svensson; Juan C Souto; Inge Scharrer; F Eric Preston; Gualtiero Palareti; Ingrid Pabinger; Felix J M van der Meer; Mike Makris; Jordi Fontcuberta; Jacqueline Conard; Frits R Rosendaal
Recurrence rate after a first venous thrombosis in patients with familial thrombophilia.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(9):1992-7.
2005: Ingrid Pabinger; Rainer Vormittag
Thrombophilia and pregnancy outcomes.
Journal of thrombosis and haemostasis : JTH 2005;3(8):1603-10.
2005: Claudia Zoghlami-Rintelen; Rainer Vormittag; Thomas Sailer; Stephan Lehr; Peter Quehenberger; Helmut Rumpold; Christoph Male; Ingrid Pabinger
The presence of IgG antibodies against beta2-glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulant.
Journal of thrombosis and haemostasis : JTH 2005;3(6):1160-5.
2005: Ingrid Pabinger; Helga Grafenhofer; Alexandra Kaider; Paul A Kyrle; Peter Quehenberger; Christine Mannhalter; Klaus Lechner
Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2005;3(5):949-54.
2005: Heinz Gisslinger; Marcus Müllner; Ingrid Pabinger; Navide Heis-Vahidi-Fard; Bettina Gisslinger; Andrea Brichta; Thomas Bachleitner-Hofmann; Christine Mannhalter
Mutation of the prothrombin gene and thrombotic events in patients with polycythemia vera or essential thrombocythemia: a cohort study.
Haematologica 2005;90(3):408-10.
2005: Carla Y Vossen; Jacqueline Conard; Jordi Fontcuberta; Mike Makris; Felix J M van der Meer; Ingrid Pabinger; Gualtiero Palareti; F Eric Preston; Inge Scharrer; Juan C Souto; Peter Svensson; Isobel D Walker; Frits R Rosendaal
Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT).
Journal of thrombosis and haemostasis : JTH 2005;3(3):459-64.
2005: Thomas Sailer; Rainer Vormittag; Ingrid Pabinger; Thomas Vukovich; Stephan Lehr; Peter Quehenberger; Simon Panzer; Klaus Lechner; Claudia Zoghlami-Rintelen
Inflammation in patients with lupus anticoagulant and implications for thrombosis.
The Journal of rheumatology 2005;32(3):462-8.
2005: Katharina Schallmoser; Christiane Rosin; Regina Knittelfelder; Thomas Sailer; Silvia Ulrich; Claudia Zoghlami; Stephan Lehr; Ingrid Pabinger; Simon Panzer
The Fc gammaRIIa polymorphism R/H131, autoantibodies against the platelet receptors GPIb alpha and Fc gammaRIIa and a risk for thromboembolism in lupus anticoagulant patients.
Thrombosis and haemostasis 2005;93(3):544-8.
2005: Rainer Vormittag; Thomas Vukovich; Verena Schönauer; Stephan Lehr; Erich Minar; Christine Bialonczyk; Michael M Hirschl; Ingrid Pabinger
Basal high-sensitivity-C-reactive protein levels in patients with spontaneous venous thromboembolism.
Thrombosis and haemostasis 2005;93(3):488-93.
2004: Carla Y Vossen; Jacqueline Conard; Jordi Fontcuberta; Mike Makris; Felix J M van der Meer; Ingrid Pabinger; Gualtiero Palareti; F Eric Preston; Inge Scharrer; Juan C Souto; Peter Svensson; Isobel D Walker; Frits R Rosendaal
Familial thrombophilia and lifetime risk of venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2004;2(9):1526-32.
2004: Matthias Hoke; Paul A Kyrle; Karl Philipp; Ingrid Pabinger; Alexandra Kaider; Verena Schönauer; Peter Quehenberger; Sabine Eichinger
Prospective evaluation of coagulation activation in pregnant women receiving low-molecular weight heparin.
Thrombosis and haemostasis 2004;91(5):935-40.
2004: Carla Y Vossen; F Eric Preston; Jacqueline Conard; Jordi Fontcuberta; Mike Makris; Felix J M van der Meer; Ingrid Pabinger; Gualtiero Palareti; Inge Scharrer; Juan C Souto; Peter Svensson; Isobel D Walker; Frits R Rosendaal
Hereditary thrombophilia and fetal loss: a prospective follow-up study.
Journal of thrombosis and haemostasis : JTH 2004;2(4):592-6.
2004: Silke Ehrenforth; László Nemes; Christine Mannhalter; F R Rosendaal; Silvia Koder; Claudia Zoghlami-Rintelen; Inge Scharrer; Ingrid Pabinger
Impact of environmental and hereditary risk factors on the clinical manifestation of thrombophilia in homozygous carriers of factor V:G1691A.
Journal of thrombosis and haemostasis : JTH 2004;2(3):430-6.
2004: Georgios Karanikas; Konstantin Zedwitz-Liebenstein; Harald Eidherr; Matthias Schuetz; Robert Sauerman; Robert Dudczak; Stefan Winkler; Ingrid Pabinger; Kurt Kletter
Platelet kinetics and scintigraphic imaging in thrombocytopenic malaria patients.
Thrombosis and haemostasis 2004;91(3):553-7.
2003: Ingrid Pabinger; Helga Grafenhofer
Anticoagulation during pregnancy.
Seminars in thrombosis and hemostasis 2003;29(6):633-8.
2003: Kety Hsieh; Paul Knoebl; Claudia Rintelen; Paul A Kyrle; Peter Quehenberger; Christine Bialonczyk; Hugo Partsch; Klaus Lechner; Ingrid Pabinger
Is the determination of anti-beta2 glycoprotein I antibodies useful in patients with venous thromboembolism without the antiphospholipid syndrome?
British journal of haematology 2003;123(3):490-5.
2003: Ingrid Pabinger; Helga Grafenhofer
Pregnancy-associated thrombosis.
Wiener klinische Wochenschrift 2003;115(13-14):482-4.
2003: Ute Priglinger; Georg Delle-Karth; Alexander Geppert; Christian Joukhadar; Senta Graf; Rudolf Berger; M Hülsmann; Susanne Spitzauer; Ingrid Pabinger; Gottfried Heinz
Prophylactic anticoagulation with enoxaparin: Is the subcutaneous route appropriate in the critically ill?
Critical care medicine 2003;31(5):1405-9.
2003: Claudia Zoghlami-Rintelen; Ansgar Weltermann; C Bittermann; Paul A Kyrle; Ingrid Pabinger; Klaus Lechner; E Wenzl
Efficacy and safety of splenectomy in adult chronic immune thrombocytopenia.
Annals of hematology 2003;82(5):290-4.
2003: Thomas Sailer; Ansgar Weltermann; Claudia Zoghlami; Paul A Kyrle; Klaus Lechner; Ingrid Pabinger
Mortality in severe, non aggressively treated adult autoimmune thrombocytopenia.
The hematology journal : the official journal of the European Haematology Association / EHA 2003;4(5):366-9.
2002: Ingrid Pabinger; Helga Grafenhofer
Thrombosis during pregnancy: risk factors, diagnosis and treatment.
Pathophysiology of haemostasis and thrombosis 2002;32(5-6):322-4.
2002: Marco Ruggeri; Heinz Gisslinger; Alberto Tosetto; Claudia Rintelen; Christine Mannhalter; Ingrid Pabinger; Navide Heis; Giancarlo Castaman; Edoardo Missiaglia; Klaus Lechner; Francesco Rodeghiero
Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
American journal of hematology 2002;71(1):1-6.
2002: Ingrid Pabinger; Helga Grafenhofer; Paul A Kyrle; Peter Quehenberger; Christine Mannhalter; Klaus Lechner; Alexandra Kaider
Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism.
Blood 2002;100(3):1060-2.
2002: Michael Krebs; B Meyer; P Quehenberger; Peter L Turecek; M Hejna; Wolfgang R Sperr; Klaus Lechner; Ingrid Pabinger
Massive postoperative intramuscular bleeding in acquired von Willebrand's disease.
Annals of hematology 2002;81(7):394-6.
2002: Catharina Wenzel; Brigitte Stoiser; Gottfried J Locker; Klaus Laczika; Peter Quehenberger; Stylianos Kapiotis; Michael Frass; Ingrid Pabinger; Paul Knoebl
Frequent development of lupus anticoagulants in critically ill patients treated under intensive care conditions.
Critical care medicine 2002;30(4):763-70.
2001: Thomas Neunteufl; Sandra Heher; Thomas Stefenelli; Ingrid Pabinger; Heinz Gisslinger
Endothelial dysfunction in patients with polycythaemia vera.
British journal of haematology 2001;115(2):354-9.
2001: Stefan Kuhle; D A Lane; K Jochmanns; Christoph Male; Peter Quehenberger; Klaus Lechner; Ingrid Pabinger
Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism.
Thrombosis and haemostasis 2001;86(4):1007-11.
2001: Claudia Rintelen; Ingrid Pabinger; P Bettelheim; Klaus Lechner; Paul A Kyrle; Paul Knoebl; Barbara Schneider; Christine Mannhalter
Impact of the factor II: G20210A variant on the risk of venous thromboembolism in relatives from families with the factor V: R506Q mutation.
European journal of haematology 2001;67(3):165-9.
2001: Ingrid Pabinger; Helga Grafenhofer; Alexandra Kaider; A Ilic; Sabine Eichinger; Peter Quehenberger; Peter Husslein; Christine Mannhalter; Klaus Lechner
Preeclampsia and fetal loss in women with a history of venous thromboembolism.
Arteriosclerosis, thrombosis, and vascular biology 2001;21(5):874-9.
2001: Martin Jansen; Sabine Schmaldienst; Susanne Banyai; Peter Quehenberger; Ingrid Pabinger; Kurt Derfler; Walter H Hörl; Paul Knoebl
Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb).
British journal of haematology 2001;112(1):91-7.
2000: Ingrid Pabinger; László Nemes; Claudia Rintelen; Silvia Koder; E Lechler; R M Loreth; Paul A Kyrle; Inge Scharrer; G Sas; Klaus Lechner; Christine Mannhalter; Silke Ehrenforth
Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden.
The hematology journal : the official journal of the European Haematology Association / EHA 2000;1(1):37-41.
1999: P Meidlinger; Paul Knoebl; Ulrich Jäger; Heinz Gisslinger; Ingrid Pabinger; Ansgar Weltermann; Klaus Lechner; Klaus Geissler
Granulocyte colony-stimulating factor-supported combined immunosuppressive therapy (antilymphocyte globulin, cyclosporine, and methylprednisolone) in patients with aplastic anemia: tolerability, efficacy, and changes in the progenitor cell compartment.
Annals of hematology 1999;78(7):299-304.
1999: Heinz Gisslinger; Francesco Rodeghiero; M Ruggeri; Navide Heis-Vahidi-Fard; Christine Mannhalter; Menelaos Papagiannopoulos; Claudia Rintelen; W Lalouschek; Paul Knoebl; Klaus Lechner; Ingrid Pabinger
Homocysteine levels in polycythaemia vera and essential thrombocythaemia.
British journal of haematology 1999;105(2):551-5.
1999: Claudia Rintelen; Christine Mannhalter; Klaus Lechner; Sabine Eichinger; Paul A Kyrle; Menelaos Papagiannopoulos; Barbara Schneider; Ingrid Pabinger
No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1999;10(2):101-5.
1999: Christoph Male; Klaus Lechner; Sabine Eichinger; Paul A Kyrle; Stylianos Kapiotis; Herbert Wank; A Kaider; Ingrid Pabinger
Clinical significance of lupus anticoagulants in children.
The Journal of pediatrics 1999;134(2):199-205.
1998: Sabine Eichinger; A Stümpflen; Michael M Hirschl; Christine Bialonczyk; Kurt Herkner; Milena Stain; Barbara Schneider; Ingrid Pabinger; Klaus Lechner; Paul A Kyrle
Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism.
Thrombosis and haemostasis 1998;80(4):566-9.
1998: Paul A Kyrle; Christine Mannhalter; S Béguin; A Stümpflen; Michael M Hirschl; Ansgar Weltermann; Milena Stain; B Brenner; Wolfgang Speiser; Ingrid Pabinger; Klaus Lechner; Sabine Eichinger
Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothrombin gene.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(8):1287-91.
1998: Ansgar Weltermann; Ingrid Pabinger; Klaus Geissler; Ulrich Jäger; Heinz Gisslinger; Paul Knoebl; Sabine Eichinger; Paul A Kyrle; Peter Valent; Wolfgang Speiser; Ilse Schwarzinger; Christine Mannhalter; Klaus Lechner
Hypofibrinogenemia in non-M3 acute myeloid leukemia. Incidence, clinical and laboratory characteristics and prognosis.
Leukemia 1998;12(8):1182-6.
1998: S Mustafa; Christine Mannhalter; Claudia Rintelen; Paul A Kyrle; Paul Knoebl; Klaus Lechner; Ingrid Pabinger
Clinical features of thrombophilia in families with gene defects in protein C or protein S combined with factor V Leiden.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1998;9(1):85-9.
1997: Paul A Kyrle; A Stümpflen; Michael M Hirschl; Christine Bialonczyk; Kurt Herkner; Wolfgang Speiser; Ansgar Weltermann; Alexandra Kaider; Ingrid Pabinger; Klaus Lechner; Sabine Eichinger
Levels of prothrombin fragment F1+2 in patients with hyperhomocysteinemia and a history of venous thromboembolism.
Thrombosis and haemostasis 1997;78(5):1327-31.
1997: S Mustafa; Ingrid Pabinger; K Vàradi; Walter-Michael Halbmayer; Klaus Lechner; H P Schwarz; M Fischer; Christine Mannhalter
A hitherto unknown splice site defect in the protein S gene (PROS1): the mutation results in allelic exclusion and causes type I and type III protein S deficiency.
British journal of haematology 1997;99(2):298-300.
1997: Katharina Ruzicka; Stylianos Kapiotis; Peter Quehenberger; Sylvia Handler; Stephan Hornykewycz; A Michitsch; Kurt Huber; D Clemens; M Susan; Ingrid Pabinger; Sabine Eichinger; Bernd Jilma; Wolfgang Speiser
Evaluation of bedside prothrombin time and activated partial thromboplastin time measurement by coagulation analyzer CoaguCheck Plus in various clinical settings.
Thrombosis research 1997;87(5):431-40.
1997: Simon Panzer; Ingrid Pabinger; Michael E Gschwandtner; Wolfgang R Mayr; D Hütter
Lupus anticoagulants: strong association with the major histocompatibility complex class II and platelet antibodies.
British journal of haematology 1997;98(2):342-5.
1997: Manuela Födinger; Christine Mannhalter; G Wölfl; Ingrid Pabinger; E Müller; R Schmid; Walter H Hörl; Gere Sunder-Plassmann
Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients.
Kidney international 1997;52(2):517-23.
1997: Klaus Geissler; E Koller; E Hubmann; Dietger Niederwieser; Wolfgang Hinterberger; D Geissler; Paul A Kyrle; Paul Knoebl; Ingrid Pabinger; Renate Thalhammer; Ilse Schwarzinger; Christine Mannhalter; Ulrich Jaeger; R Heinz; Werner Linkesch; Klaus Lechner
Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia--a randomized phase-III study.
Blood 1997;90(2):590-6.
1997: S Mustafa; Ingrid Pabinger; Christine Mannhalter
A frequent mutation in the protein S gene results in cryptic splicing.
British journal of haematology 1997;97(3):555-7.
1997: Simon Panzer; Michael E Gschwandtner; D Hütter; S Spitzauer; Ingrid Pabinger
Specificities of platelet autoantibodies in patients with lupus anticoagulants in primary antiphospholipid syndrome.
Annals of hematology 1997;74(5):239-42.
1997: Paul A Kyrle; Sabine Eichinger; Ingrid Pabinger; A Stümpflen; Michael M Hirschl; Christine Bialonczyk; Barbara Schneider; Christine Mannhalter; M Melichart; G Traxler; Ansgar Weltermann; Wolfgang Speiser; Klaus Lechner
Prothrombin fragment F1+2 is not predictive for recurrent venous thromboembolism.
Thrombosis and haemostasis 1997;77(5):829-33.
1997: Sabine Eichinger; Ingrid Pabinger; A Stümpflen; Michael M Hirschl; Christine Bialonczyk; Barbara Schneider; Christine Mannhalter; Erich Minar; Klaus Lechner; Paul A Kyrle
The risk of recurrent venous thromboembolism in patients with and without factor V Leiden.
Thrombosis and haemostasis 1997;77(4):624-8.
1997: Claudia Rintelen; Ingrid Pabinger; Klaus Lechner; Christine Mannhalter
Impact of factor V Leiden mutation on duration of anticoagulation after a single thromboembolic event.
Thrombosis and haemostasis 1997;77(2):405.
1996: Claudia Rintelen; Christine Mannhalter; Ingrid Pabinger; Inge Scharrer; S Klinke
Oral anticoagulants and fetal loss.
Lancet 1996;348(9043):1735.
1996: I M Huhmann; Herbert H Watzke; Klaus Geissler; Heinz Gisslinger; Ulrich Jäger; Paul Knoebl; Ingrid Pabinger; L Korninger; Christine Mannhalter; Gerlinde Mitterbauer; Ilse Schwarzinger; Peter Kalhs; Oskar A Haas; Klaus Lechner
FLAG (fludarabine, cytosine arabinoside, G-CSF) for refractory and relapsed acute myeloid leukemia.
Annals of hematology 1996;73(6):265-71.
1996: Margit Mitterbauer; Monika Fritzer-Szekeres; Gerlinde Mitterbauer; Ingrid Simonitsch; Paul Knoebl; Claudia Rintelen; Ilse Schwarzinger; Oskar A Haas; K Silberbauer; K Frey; B Bibus; Ingrid Pabinger; T Radaszkiewicz; Klaus Lechner; Ulrich Jaeger
Spontaneous remission of acute myeloid leukemia after infection and blood transfusion associated with hypergammaglobulinaemia.
Annals of hematology 1996;73(4):189-93.
1996: S Mustafa; Ingrid Pabinger; Christine Mannhalter
Two new frequent dimorphisms in the protein S (PROS1) gene.
Thrombosis and haemostasis 1996;76(3):393-6.
1996: Ingrid Pabinger; B Schneider
Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. A cooperative, retrospective study. Gesellschaft fur Thrombose- und Hamostaseforschung (GTH) Study Group on Natural Inhibitors.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(6):742-8.
1996: Claudia Rintelen; Christine Mannhalter; H Ireland; D A Lane; Paul Knoebl; Klaus Lechner; Ingrid Pabinger
Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden.
British journal of haematology 1996;93(2):487-90.
1996: Michael E Gschwandtner; Sabine Eichinger; D Hütter; L Korninger; Klaus Lechner; Simon Panzer; Ingrid Pabinger
Lupus anticoagulant and thromboembolism: evaluation of fibrinogen, natural inhibitors and molecular markers of thrombosis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1996;7(3):325-30.
1996: Manuela Födinger; Christine Mannhalter; Ingrid Pabinger; D Koizar; Claudia Rintelen; Walter H Hörl; Gere Sunder-Plassmann
Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11(4):668-72.
1996: Florian Thalhammer; Klaus Geissler; Ulrich Jäger; Paul A Kyrle; Ingrid Pabinger; Margit Mitterbauer; Heinz Gisslinger; Paul Knoebl; Klaus Laczika; B Schneider; Oskar A Haas; Klaus Lechner
Duration of second complete remission in patients with acute myeloid leukemia treated with chemotherapy: a retrospective single-center study.
Annals of hematology 1996;72(4):216-22.
1996: Claudia Rintelen; Ingrid Pabinger; Paul Knoebl; Klaus Lechner; Christine Mannhalter
Probability of recurrence of thrombosis in patients with and without factor V Leiden.
Thrombosis and haemostasis 1996;75(2):229-32.
1996: M Melichart; Paul A Kyrle; Sabine Eichinger; Claudia Rintelen; Christine Mannhalter; Ingrid Pabinger
Thrombotic tendency in 75 symptomatic, unrelated patients with APC resistance.
Wiener klinische Wochenschrift 1996;108(19):607-10.
1995: S Mustafa; Ingrid Pabinger; Christine Mannhalter
Protein S deficiency type I: identification of point mutations in 9 of 10 families.
Blood 1995;86(9):3444-51.
1995: Paul Knoebl; Kurt Derfler; L Korninger; Stylianos Kapiotis; Ulrich Jäger; T Maier-Dobersberger; Walter H Hörl; Klaus Lechner; Ingrid Pabinger
Elimination of acquired factor VIII antibodies by extracorporal antibody-based immunoadsorption (Ig-Therasorb).
Thrombosis and haemostasis 1995;74(4):1035-8.
1995: Michael E Gschwandtner; Klaus Lechner; Ingrid Pabinger
Erroneously low APC ratio in patients with lupus anticoagulant.
Annals of hematology 1995;70(3):169-70.
1994: Alexander Gaiger; Alexander Neumeister; Harald Heinzl; Ingrid Pabinger; Simon Panzer
HLA class-I and -II antigens in chronic idiopathic autoimmune thrombocytopenia.
Annals of hematology 1994;68(6):299-302.
1994: Ingrid Pabinger; B Schneider
Thrombotic risk of women with hereditary antithrombin III-, protein C- and protein S-deficiency taking oral contraceptive medication. The GTH Study Group on Natural Inhibitors.
Thrombosis and haemostasis 1994;71(5):548-52.
1994: Ingrid Pabinger; Paul A Kyrle; M Heistinger; Sabine Eichinger; E Wittmann; Klaus Lechner
The risk of thromboembolism in asymptomatic patients with protein C and protein S deficiency: a prospective cohort study.
Thrombosis and haemostasis 1994;71(4):441-5.
1993: Ulrich Jaeger; Stylianos Kapiotis; Ingrid Pabinger; E Puchhammer; Paul A Kyrle; Klaus Lechner
Transient lupus anticoagulant associated with hypoprothrombinemia and factor XII deficiency following adenovirus infection.
Annals of hematology 1993;67(2):95-9.
1993: I Hauser; Heinz Gisslinger; Gottfried J Locker; W Elbl; Paul A Kyrle; Ingrid Pabinger; Klaus Lechner
Postpartum factor VIII inhibitors. Report of two cases with special reference to the efficacy of various treatments.
Wiener klinische Wochenschrift 1993;105(12):355-8.
1992: Ilse Schwarzinger; M Stain-Kos; P Bettelheim; Ingrid Pabinger; Paul A Kyrle; Peter Kalhs; Stylianos Kapiotis; Ulrich Jäger; Klaus Lechner
Recurrent, isolated factor X deficiency in myeloma: repeated normalization of factor X levels after cytostatic chemotherapy followed by late treatment failure associated with the development of systemic amyloidosis.
Thrombosis and haemostasis 1992;68(6):648-51.
1992: Ingrid Pabinger; C F Allaart; J Hermans; E Briët; R M Bertina
Hereditary protein C-deficiency: laboratory values in transmitters and guidelines for the diagnostic procedure. Report on a study of the SSC Subcommittee on Protein C and Protein S. Protein C Transmitter Study Group.
Thrombosis and haemostasis 1992;68(4):470-4.
1992: Ingrid Pabinger; S Brücker; Paul A Kyrle; B Schneider; H C Korninger; H Niessner; Klaus Lechner
Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1992;3(5):547-53.
1992: M Heistinger; E Rumpl; H Illiasch; H Türck; Paul A Kyrle; Klaus Lechner; Ingrid Pabinger
Cerebral sinus thrombosis in a patient with hereditary protein S deficiency: case report and review of the literature.
Annals of hematology 1992;64(2):105-9.
1992: K Lechner; Alexander Gaiger; A Fritz; P Kyrle; Sabine Eichinger; Ingrid Pabinger
[Problems of long-term therapy with anticoagulants].
Acta medica Austriaca 1992;19(1):21-4.
1992: Sabine Eichinger; Ingrid Pabinger; Paul A Kyrle; U Köller; P Kier; B Schneider; Klaus Lechner
Factor VIII concentrates in HIV-1-positive hemophiliacs--is pure better?
Haemostasis 1992;22(1):25-31.
1991: Ingrid Pabinger; P Bettelheim; R Dudczak; Wolfgang Hinterberger; Paul A Kyrle; H Niessner; Ilse Schwarzinger; Wolfgang Speiser; Klaus Lechner
Coincidence of acquired factor-X deficiency and disseminated intravascular coagulation in patients with acute nonlymphoblastic leukemia.
Annals of hematology 1991;62(5):174-9.
1991: M Hinterberger-Fischer; P Kier; Peter Kalhs; Christine Marosi; Klaus Geissler; Ilse Schwarzinger; Ingrid Pabinger; J Huber; J Spona; H Kolbabek
Fertility, pregnancies and offspring complications after bone marrow transplantation.
Bone marrow transplantation 1991;7(1):5-9.
1990: M Heistinger; F Stockenhuber; B Schneider; Ingrid Pabinger; B Brenner; B Wagner; P Balcke; Klaus Lechner; Paul A Kyrle
Effect of conjugated estrogens on platelet function and prostacyclin generation in CRF.
Kidney international 1990;38(6):1181-6.
1990: Sabine Eichinger; Ingrid Pabinger; H Hartl; C Stain; S Mayerhofer; C Schweiger; P Kier; Ilse Schwarzinger; Paul A Kyrle; Klaus Lechner
Azidothymidine (AZT) in the treatment of symptomatic HIV-1-infected hemophiliacs.
Thrombosis and haemostasis 1990;64(1):108-12.
1990: Ingrid Pabinger; Paul A Kyrle; Wolfgang Speiser; U Stoffels; M Jung; Klaus Lechner
Diagnosis of protein C deficiency in patients on oral anticoagulant treatment: comparison of three different functional protein C assays.
Thrombosis and haemostasis 1990;63(3):407-12.
1990: Manfred Muhm; N Grois; P Kier; A Stümpflen; Paul A Kyrle; Ingrid Pabinger; P Bettelheim; Wolfgang Hinterberger; Klaus Lechner
1-Deamino-8-D-arginine vasopressin in the treatment of non-haemophilic patients with acquired factor VIII inhibitor.
Haemostasis 1990;20(1):15-20.
1988: Paul A Kyrle; F Stockenhuber; B Brenner; Heinz D Gössinger; C Korninger; Ingrid Pabinger; Gere Sunder-Plassmann; P Balcke; Klaus Lechner
Evidence for an increased generation of prostacyclin in the microvasculature and an impairment of the platelet alpha-granule release in chronic renal failure.
Thrombosis and haemostasis 1988;60(2):205-8.
1987: Ingrid Pabinger; H Niessner; C Korninger; C Nowotny; Milena Stain; Paul A Kyrle; Klaus Lechner
[Home treatment in hemophilia].
Wiener klinische Wochenschrift 1987;99(22):773-7.
1987: K Lechner; C Korninger; P Kyrle; K Geissler; H Niessner; Ingrid Pabinger; S Panzer; Heinz D Gössinger; P Bettelheim; W Hinterberger
[Oral anticoagulant therapy--renaissance of an old therapy?].
Wiener klinische Wochenschrift 1987;99(7):203-10.
1987: Ilse Schwarzinger; Ingrid Pabinger; C Korninger; F Haschke; M Kundi; H Niessner; K Lechner
Incidence of inhibitors in patients with severe and moderate hemophilia A treated with factor VIII concentrates.
American journal of hematology 1987;24(3):241-5.
1987: Ingrid Pabinger; G Heinz; R Vikydal; W Schlick
[Various forms of hypoventilation syndromes].
Wiener medizinische Wochenschrift. Supplement 1987;103():46-7.
1985: R Vikydal; C Korninger; P A Kyrle; H Niessner; Ingrid Pabinger; E Thaler; K Lechner
The prevalence of hereditary antithrombin-III deficiency in patients with a history of venous thromboembolism.
Thrombosis and haemostasis 1985;54(4):744-5.
1985: P A Kyrle; C Korninger; Heinz D Gössinger; D Glogar; K Lechner; H Niessner; Ingrid Pabinger
Prevention of arterial and pulmonary embolism by oral anticoagulants in patients with dilated cardiomyopathy.
Thrombosis and haemostasis 1985;54(2):521-3.
1985: M Fischer; K Lechner; W Hinterberger; H Niessner; Ingrid Pabinger; R Dudczak; E Neumann; C Korninger; E Deutsch
Deficiency of fibrinogen and factor VII following treatment of severe aplastic anaemia with anti-thymocyte globulin and high-dose methylprednisolone.
Scandinavian journal of haematology 1985;34(4):312-6.